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ABSTRACT
Neuroinflammation has been implicated in the pathogenesis o f Alzheimer’s Disease 
(AD) and often characterized by activation of glial cells and the subsequent up- 
regulation of various cytokines. Neuronal damage would then set in and lead to 
deterioration of cognitive function. Virgin Coconut Oil (VCO) has been reported to 
possess anti-bacterial, anti-viral, anti-oxidants and anti-inflammatory properties. 
Capitalizing on these therapeutic effects, the present study investigated for the first 
time the potential neuroprotective effect o f VCO in vitro and in vivo. For this purpose, 
neuroprotection by VCO against amyloid-/3-(A/3) and Lipopolysaccharide(LPS)- 
induced cell death and Reactive Oxygen Species (ROS) production of SK-N-SH 
(neuroblastoma cells) was assessed. The in vitro findings were validated using normal 
and LPS-induced memory impaired animal models in vivo. A total of 36 male Wistar 
rats (7-8 weeks) were randomly assigned to 6 groups (n=6/group). The treatment 
groups were administered with 1, 5 and lOmL/kg o f VCO for 31 days by oral gavages. 
The cognitive functions of the treated-rats were then assessed using the Morris Water 
Maze Test. Collected brains were homogenised and subjected to biochemical analyses 
o f Acetylcholine (ACh), Acetylcholinesterase (AChE), antioxidative enzymes 
[Superoxide dismutase (SOD), Catalase (CAT), Glutathione (GSH), Glutathione 
peroxidase (GPx) and Glutathione reductase (GRx)], lipid peroxidase 
[Malondialdehyde (MDA)], nitric oxide (NO), cytokines (IL1-/3, IFN-y and IL-10) as 
well as inflammatory (COX-2 and iNOS) and amyloidogenic genes (BACE-1). Next, 
yet another 48 male Wistar rats (7-8 weeks) were assigned for neuroinflammatory 
study. The treatment groups (1, 5 and lOml/kg) were administered with 1, 5 and 
1 OmL/kg of VCO for 31 days by oral gavage in the presence o f 0.25 mg/kg LPS (i.p.). 
a-Tocopherol (150 mg/kg) was used as positive control throughout the in vivo studies. 
The results showed that 100|ag/mL VCO significantly improved viability of SK-N-SH 
(+47.25%; p<0.01 and 57.46%; p<0.001) and inhibited ROS production (-18.36%; 
p<0.001 and -30.96%; p<0.001) in the presence o f A/3 and LPS respectively. 
Subsequent validation in normal rats indicated that VCO significantly enhanced 
cognitive functions [escape latency (-29.62±1.22%), escape distance (-23.87±0.20%) 
and total time spent on platform (+36.84%; p<0.05)]. The findings were mediated 
through elevation of ACh (+15.39%; p<0.001), SOD (+8.30%; p<0.05), CAT 
(+67.15%; p<0.001), GSH (+30.45%; p<0.001) and GPx (+14.31%; p<0.001) and 
reduction o f AChE (-23.16%; p<0.001), MDA (-45.14%; p<0.001) and NO (-65.38%; 
p<0.001). On the other hand, exposure of LPS-induced memory impaired rats to VCO 
resulted significantly improved cognitive functions [escape latency(-45.87±0.61%), 
escape distance (-32.63+0.24%) and total time spent on platform (+81.82%; p<0.01)]. 
The improvements were mediated through elevation of ACh (+26.80%; p<0.001), 
SOD (+8.25%; p<0.05), CAT (+69.50%; p<0.001), GSH (+99.27%; p<0.001), GPx 
(+15.10%; p<0.001), GRx (+26.40%; p<0.001) and IL-10 (+34.05%; p<0.01) and 
reduction of AChE (-44.83%; p<0.001), MDA (-58.73%; p<0.001), NO (-52.71%; 
p<0.001), IL-10 (-64.85%; p<0.001), IFN-y (-25.03%; p<0.05), COX-2 (-67.73%; 
p<0.001), iNOS (-65.63%; p<0.001) and BACE-1 (-75%; p<0.001). The present 
findings strongly implied that VCO has neuroprotective effects and has the potential 
to be a memory enhancer. This neuroprotective effect was mediated, at least in part, 
through the inflammatory, cholinergic and amyloidogenic pathways.
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CHAPTER ONE 
INTRODUCTION
Neurodegenerative diseases occur when neurons in the brain or spinal cord 
begin to deteriorate. Changes in these cells cause them to function abnormally and 
eventually result in cell death. The progression of this condition will lead to 
impairment in memory, judgement, decision making and language ability (Thies & 
Bleiler, 2011). Alzheimer’s disease (AD) is the most well-known neurodegenerative 
disease without cure (Choi, Lee, Hong, & Lee, 2012). In fact, it is the leading cause of 
dementia (especially among the elderly population) (Um, Ahn, Kim, & Ha, 2012) 
characterized by progressive memory loss and deterioration in cognitive abilities 
(Lemere & Masliah, 2010). In 2013, about 35 million people worldwide were living 
with AD. The number is expected to double by 2030 and more than triple by 2050 
reaching 115 million people worldwide (Prince, Guerchet, & Prina, 2013). In 
Malaysia, about 50,000 people are suffering from AD (ADFM, 2014). The number, 
however, could be higher given that not all are officially diagnosed. The continuous 
rise of AD has brought about huge economic and personal burden to current and 
future generations both through direct (medical and social care) and indirect (care 
giving by families and friends) cost (Wimo, Jonsson, Bond, Prince, & Winblad, 2013).
The pathogenesis of AD remains poorly understood. Nevertheless, excessive 
aggregation o f /3-amyloid peptide (A/3) has been found to be associated with the 
development and progression of AD (Dhanasekaran, Holcomb, Hitt, Tharakan, Porter 
et al., 2009). A/3 is a peptide derived from proteolysis o f amyloid precursor protein 
(APP). Recently, several lines of evidence have further uncovered the correlation 
between oxidative stress and pathogenesis of AD (Zhang, Yu, Zhao, Lin, Tan et al.,
2010). It was found that A/3 induces oxidative stress by causing mitochondrial 
dysfunction that may in turn result in increased reactive oxygen species (ROS). ROS 
is known to not only oxidise vital cellular components but also alter several signalling 
pathways including apoptosis by modulation of Bcl-2 and p53 protein (Brunet, Datta, 
& Greenberg, 2001; Dypbukt, Ankarcrona, Burkitt, Sjoholm, Strom et al., 1994). As 
such, excessive production of ROS can cause cellular damage and subsequently cell 
death.
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